XEOJO Trademark

Trademark Overview


On Thursday, July 15, 2021, a trademark application was filed for XEOJO with the United States Patent and Trademark Office. The USPTO has given the XEOJO trademark a serial number of 79318935. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, November 3, 2022. This trademark is owned by NOVARTIS AG. The XEOJO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
xeojo

General Information


Serial Number79318935
Word MarkXEOJO
Filing DateThursday, July 15, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, November 3, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma, all of the foregoing goods excluding botulinim toxin

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 3, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, November 27, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 3, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 3, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, March 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, November 3, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, November 3, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, November 3, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, April 22, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, April 22, 2022FINAL REFUSAL E-MAILED
Friday, April 22, 2022FINAL REFUSAL WRITTEN
Wednesday, March 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 23, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 12, 2021REFUSAL PROCESSED BY IB
Thursday, November 18, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 18, 2021REFUSAL PROCESSED BY MPU
Friday, October 22, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 21, 2021NON-FINAL ACTION WRITTEN
Monday, October 18, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, October 18, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, October 16, 2021ASSIGNED TO EXAMINER
Tuesday, October 5, 2021CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Sunday, September 19, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, September 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 7, 2021APPLICATION FILING RECEIPT MAILED
Friday, September 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 2, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 26, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB